Loading…
Lobbying Spend
—
Filings
150
Firms Hired
3
Active Period
1999–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Inflation Reduction Act of 2022
2022 · second_quarter · Firm: SIMS STRATEGIES, LLC
Issues related to vaccine policy and patient cost sharing, including in H.R. 5376, the Build Back Better Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 5376
American Rescue Plan Act of 2021
2021 · first_quarter · Firm: SIMS STRATEGIES, LLC
Drug cost and pricing policy issues. Issues related to drug policies in H.R. 1319, American Rescue Plan Act (P.L. 117-2), including Medicaid rebates.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1319
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
2020 · first_quarter · Firm: SIMS STRATEGIES, LLC
Issues related to vaccines in H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 6074
Drug cost and pricing policy issues. S. 2543, the Prescription Drug Pricing Reduction Act. S. 1895, the Lower Health Care Costs Act.
Client expense: — · Firm income: $40,000
Matched citations: S. 1895
Prescription Drug Pricing Reduction Act of 2019
2020 · first_quarter · Firm: SIMS STRATEGIES, LLC
Drug cost and pricing policy issues. S. 2543, the Prescription Drug Pricing Reduction Act. S. 1895, the Lower Health Care Costs Act.
Client expense: — · Firm income: $40,000
Matched citations: S. 2543
Drug cost and pricing policy issues. S. 2543, the Prescription Drug Pricing Reduction Act. S. 1895, the Lower Health Care Costs Act.
Client expense: — · Firm income: $40,000
Matched citations: S. 1895
Prescription Drug Pricing Reduction Act of 2019
2019 · fourth_quarter · Firm: SIMS STRATEGIES, LLC
Drug cost and pricing policy issues. S. 2543, the Prescription Drug Pricing Reduction Act. S. 1895, the Lower Health Care Costs Act.
Client expense: — · Firm income: $40,000
Matched citations: S. 2543
Drug cost and pricing policy issues. S. 2543, the Prescription Drug Pricing Reduction Act. S. 1895, the Lower Health Care Costs Act.
Client expense: — · Firm income: $40,000
Matched citations: S. 1895
Prescription Drug Pricing Reduction Act of 2019
2019 · third_quarter · Firm: SIMS STRATEGIES, LLC
Drug cost and pricing policy issues. S. 2543, the Prescription Drug Pricing Reduction Act. S. 1895, the Lower Health Care Costs Act.
Client expense: — · Firm income: $40,000
Matched citations: S. 2543
Over-the-Counter Drug Safety, Innovation, and Reform Act
2018 · fourth_quarter · Firm: SIMS STRATEGIES, LLC
Education and importance of various pharmaceutical industry issues, including issues affecting vaccines; emerging infectious diseases within S.2852, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act; and over-the-counter monograph reform in S.2315, the Over-the-Counter Drug Safety Innovation and Reform Act.
Client expense: — · Firm income: $40,000
Matched citations: S.2315
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
2018 · fourth_quarter · Firm: SIMS STRATEGIES, LLC
Education and importance of various pharmaceutical industry issues, including issues affecting vaccines; emerging infectious diseases within S.2852, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act; and over-the-counter monograph reform in S.2315, the Over-the-Counter Drug Safety Innovation and Reform Act.
Client expense: — · Firm income: $40,000
Matched citations: S.2852
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
2018 · third_quarter · Firm: SIMS STRATEGIES, LLC
Education and importance of various pharmaceutical industry issues, including issues affecting vaccines; emerging infectious diseases within S.2852, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act.
Client expense: — · Firm income: $40,000
Matched citations: S.2852
Bipartisan Budget Act of 2018
2018 · first_quarter · Firm: SIMS STRATEGIES, LLC
Education and importance of various pharmaceutical industry issues including Medicare Part D and Medicaid; Pharmaceutical issues in H.R. 1892, the Bipartisan Budget Act of 2018.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1892
Bipartisan Budget Act of 2018
2018 · first_quarter · Firm: SIMS STRATEGIES, LLC
Education and importance of various pharmaceutical industry issues; Pharmaceutical issues in H.R. 1892, the Bipartisan Budget Act of 2018.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1892
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
2017 · fourth_quarter · Firm: SIMS STRATEGIES, LLC
International tax provisions in H.R. 1, the Tax Cuts and Jobs Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1
Consolidated Appropriations Act, 2016
2015 · fourth_quarter · Firm: CHAMBER HILL STRATEGIES
Education and importance of various pharmaceutical industry issues, including the Part D prescription drug program; and monitoring of H.R.2029, Consolidated Appropriations Act 2016.
Client expense: — · Firm income: $40,000
Matched citations: H.R.2029
Continuing Appropriations Act, 2016
2015 · third_quarter · Firm: CHAMBER HILL STRATEGIES
Education and importance of various pharmaceutical industry issues, including the Part D prescription drug program; and monitoring of and broad payment reform issues included within H.R.719, Continuing Appropriations Act 2016 and chronic care working group submission.
Client expense: — · Firm income: $40,000
Matched citations: H.R.719
Medicare Access and CHIP Reauthorization Act of 2015
2015 · second_quarter · Firm: CHAMBER HILL STRATEGIES
Education and importance of various pharmaceutical industry issues, including the Part D prescription drug program; and monitoring of and broad payment reform issues included within H.R.2, Medicare Access and CHIP Reauthorization Act of 2015.
Client expense: — · Firm income: $40,000
Matched citations: H.R.2
S.1137, The Patent Act; the Protecting American Talent and Entrepreneurship act of 2015.
Client expense: — · Firm income: $40,000
Matched citations: S.1137
Medicare Access and CHIP Reauthorization Act of 2015
2015 · first_quarter · Firm: CHAMBER HILL STRATEGIES
Education and importance of various pharmaceutical industry issues, including the Part D prescription drug program; and monitoring of and broad payment reform issues included within H.R.2, Medicare Access and CHIP Reauthorization Act of 2015.
Client expense: — · Firm income: $40,000
Matched citations: H.R.2
Better Care, Lower Cost Act
2014 · fourth_quarter · Firm: CHAMBER HILL STRATEGIES
Education and importance of various pharmaceutical industry issues, including the Part D prescription drug program; and broad payment reform issues included within P.L. 113-93, Protecting Access to Medicare Act of 2014; and S.1932, Better Care, Lower Cost Act.
Client expense: — · Firm income: $40,000
Matched citations: S.1932
Better Care, Lower Cost Act
2014 · third_quarter · Firm: CHAMBER HILL STRATEGIES
Education and importance of various pharmaceutical industry issues, including the Part D prescription drug program; and broad payment reform issues included within P.L. 113-93, Protecting Access to Medicare Act of 2014; and S.1932, Better Care, Lower Cost Act.
Client expense: — · Firm income: $40,000
Matched citations: S.1932
Better Care, Lower Cost Act
2014 · second_quarter · Firm: CHAMBER HILL STRATEGIES
Education and importance of various pharmaceutical industry issues, including the Part D prescription drug program; and broad payment reform issues included within P.L. 113-93, Protecting Access to Medicare Act of 2014; and S.1932, Better Care, Lower Cost Act.
Client expense: — · Firm income: $40,000
Matched citations: S.1932
SGR Repeal and Medicare Beneficiary Access Act of 2013
2014 · first_quarter · Firm: CHAMBER HILL STRATEGIES
Education and importance of various pharmaceutical industry issues, including the Part D prescription drug program; and broad payment reform bills S.1871, H.R.2810, S.2000, H.R.4015, S.2110, S.2157, and H.R.4302.
Client expense: — · Firm income: $40,000
Matched citations: H.R.2810
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
2014 · first_quarter · Firm: CHAMBER HILL STRATEGIES
Education and importance of various pharmaceutical industry issues, including the Part D prescription drug program; and broad payment reform bills S.1871, H.R.2810, S.2000, H.R.4015, S.2110, S.2157, and H.R.4302.
Client expense: — · Firm income: $40,000
Matched citations: H.R.4015
Source: Senate LDA